Skip to main content
. 2022 Jan 21;23(3):1200. doi: 10.3390/ijms23031200

Figure 12.

Figure 12

Evaluation of the percentage of living cells in vitro after PLGA_OXA treatment. Human cells derived from colorectal carcinoma (CaCo-2) and human primary fibroblasts (MRC-5) were treated with PLGA_OXA for 72 h.